Fractyl Health, Inc. (GUTS) Dividend History

Fractyl Health, Inc. is a clinical-stage biotech company focused on developing transformative treatments for metabolic and gastrointestinal diseases. Known for its innovative approach to advancing therapies targeting conditions like type 2 diabetes and other metabolic disorders, the company emphasizes minimally invasive procedures and novel technologies to improve patient outcomes.

3 Van De Graaff Drive, Burlington, MA, 01803
Phone: 781-902-8800
Website: https://www.fractyl.com

Dividend History

Fractyl Health, Inc. currently does not pay dividends

Company News

  • Fractyl Health, a metabolic therapeutics company, will present new preclinical data on its Rejuva Smart GLP-1 pancreatic gene therapy platform at the American Diabetes Association's 85th Scientific Sessions. The platform aims to develop novel, disease-modifying therapies for obesity and type 2 diabetes.

    GlobeNewswire Inc.
  • Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro. Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers LAMF Global Ventures Corp. I (NASDAQ: LGVC) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) gained 68.3% to $0.5389 in pre-market trading after gaining 13% on Tuesday. OneMedNet Corporation (NASDAQ: ONMD) gained 34.1% to $1.06 in pre-market trading. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares gained 28.1% to $5.01 in pre-market trading. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder. Inspire Veterinary Partners, Inc. (NASDAQ: IVP) gained 16% to $0.0545 ...

    Benzinga
    Featured Companies: CALM CISS EDBL HWH INTC IVP ONMD PLAY SINT VNDA VVPR
  • BBB Foods’ stock rises in its first day of trading as IPO market churns out deals.

    MarketWatch
    Featured Companies: ANRO KYTX PMNT TBBB
Page data last updated 07/23/2025 16:15:24 UTC